News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
The US Department of Health and Human Services is no longer recommending COVID vaccines for pregnant women and children. Big ...
The Centers for Disease Control and Prevention will no longer recommend that healthy children and pregnant women receive the COVID-19 vaccine, the Trump administration announced Tuesday. “Last ...
The CDC will no longer recommend routine Covid shots for healthy children and pregnant women, Health and Human Services ...
The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback